Skip Navigation
Small Business Innovation Research/Small Business Tech Transfer

Microfluidic Cytometer for Complete Blood Count Analysis, Phase I

Completed Technology Project

Project Description

Microfluidic Cytometer for Complete Blood Count Analysis, Phase I
RMD proposes to develop a MEMS based complete blood count (CBC) instrument that can be used aboard a spacecraft. We will produce a microfluidic scale combination cell counter-flow cytometer for CBC analyses that can be communicated to ground bases by telemetry. The blood analyzer will utilize innovative optical and fluidic designs on a modular platform that enable compactness, high sensitivity and cell discrimination, combined with robust service. No operator intervention is required. Modules that require direct contact with blood will be economical and disposable. These fluidic designs will be fabricated by microstereolithography and initially tested as two separate components. A first component will constitute a hydrodynamic focusing injector and cell impedance meter. A second component will monitor forward and side scattered light from hydrodynamically focused cells using novel signal collection designs and micrometer scale, Geiger-mode avalanche photodiodes. New, custom formulated photopolymers will be evaluated for microstereolithography use and electroless deposition of metals will form the basis for fabricating microelectrodes. During Phase II, the cell impedance transducer and microoptic modules will be integrated into one credit card size package that plugs into a handheld microelectronics board containing detectors, pump, microprocessors, and an automated cell lysing stage. More »

Primary U.S. Work Locations and Key Partners

Light bulb

Suggest an Edit

Recommend changes and additions to this project record.

This is a historic project that was completed before the creation of TechPort on October 1, 2012. Available data has been included. This record may contain less data than currently active projects.